Document is current

Any future updates will be listed below

BEGEV is an Effective Therapy for Heavily Pretreated and Platinum-Resistant Relapsed/Refractory Hodgkin’s Lymphoma Patients: A Single Center Real-Life Experience

Crossref DOI link: https://doi.org/10.1007/s12288-024-01924-6

Published Online: 2024-11-28

Published Print: 2025-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark